Microbes live in, on and around us all the time, contributing approximately 2 kilograms to our body masses. Most of them are essential for our health and live in equilibrium with our bodies. The vast majority of these microbes live in our guts and breaking this balance may have various consequences such as obesity or inflammatory bowel diseases. Knowing which microbes live in us can lead to better, personalized diets, early diagnosis, and treatment of diseases.
Thus, the original discoverers of enterotypes launched my.microbes to coordinate a large-scale scientific study open to everyone. The study aims to provide new ways of analyzing any person's gut microbes in the context of samples from many individuals around the world.
We will analyze the microbial composition and its related functions from samples that are collected non-invasively from participants. Our goal is to better understand both the similarities/differences between microbiota from different individuals and interactions between microbes and ourselves.
Participants will have an option to see how their sample is used and obtain a subset of their personal results in the context of all the others.
In line with the reduction of the overall sequencing costs, my.microbes study participation cost has been reduced to 500 EUR.
With the further expansion of our sequencing capacity and partial automation of our DNA extraction pipeline, my.microbes study participation cost has been further reduced to 550 EUR.
We have released an updated participant information package, which details various study expansions that will be implemented in the near future. In addition, my.microbes study participation cost has been further reduced to a minimum of 800 EUR.
People can be classified into one of three gut microbial types called enterotypes. Read more...